SCOPUS 정보 검색 플랫폼

Volumn 34, Issue SUPPL. 4, 2001, Pages 21-23

Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: Early results of an international phase III study

(6) Mattson, K a Abratt, R b Ten, G Velde c Krofta, K d Tonelli, D d Avril, I e

a HELSINKI UNIVERSITY CENTRAL HOSPITAL (Finland)

b UNIVERSITY OF CAPE TOWN (South Africa)

c MAASTRICHT UNIVERSITY MEDICAL CENTER (Netherlands)

d CHARLES UNIVERSITY (Czech Republic)

e SANOFI (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

ADJUVANT CHEMOTHERAPY; ASTHENIA; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG INFUSION; HUMAN; INFECTION; LUNG NON SMALL CELL CANCER; MULTICENTER STUDY; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035195359 PISSN: 01695002 EISSN: None Source Type: Journal
DOI: 10.1016/S0169-5002(01)00389-0 Document Type: Conference Paper

Times cited : (4)

References (11)

1
- 0025767652
- Induction chemotherapy for NSCLC: a consensus report
- (1991) Lung Cancer , vol.7 , pp. 15-17
- Klatersky, J.¹ Burkers, R.² Choi, N.³

2
- 0030008012
- The role of induction (neo-adjuvant) chemotherapy in stage IIIA NSCLC
- (1996) Chest , vol.109
- Rosell, R.¹ Font, A.² Pifarre, A.³

3
- 0029991284
- Benefits of neo-adjuvant chemotherapy in NSCLC
- (1996) Chest , vol.109
- Pastorino, U.¹

4
- 0028843552
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials
- (1995) Br. Med. J. , vol.311 , pp. 899-909

5
- 23444459189
- Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer
- (1994) J. Clin. Oncol. , vol.12 , pp. 1238-1244
- Fossella, F.V.¹ Lee, J.S.² Murphy, W.K.³

6
- 0028169602
- Docetaxel (Taxotere®) is active in non-small cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)
- (1994) Br. J. Cancer , vol.70 , pp. 384-387
- Cerny, T.¹ Kaplan, S.² Pavlidis, N.³

7
- 0028240902
- Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer
- (1994) J. Clin. Oncol. , vol.12 , pp. 1232-1237
- Francis, P.A.¹ Rigas, J.R.² Kris, M.G.³

8
- 0028896128
- 2 dose of docetaxel with prednisolone premedication for patients with advanced non-small-cell lung cancer
- (1995) Cancer , vol.75 , pp. 968-972
- Miller, V.A.¹ Rigas, J.R.² Francis, P.A.³

9
- 0006779620
- Mattson KV, Velde GT, Krofta K et al. Taxotere as neo-adjuvant therapy for radically-treatable stage III NSCLC. Preliminary results of an international phase III study. Proc ASCO 2000 (Abstract 1890).

10
- 0027957929
- A randomized trial comparing preoperative chemotherapy with surgery alone in patients with non-small-cell lung cancer
- (1994) New Engl. J. Med. , vol.330 , pp. 153-158
- Rosell, R.¹ Gomez-Codina, J.² Camps, C.³

11
- 0028216204
- A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
- (1994) J. Natl. Cancer Inst. , vol.86 , pp. 673-680
- Roth, J.A.¹ Fossella, F.² Komaki, R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.